Among 7 clinical domains and 3 immunological domains, SLE patients scored for the constitutional domain, hematologic domain, and mucocutaneous domain had significantly higher serum IFN activity than those who did not (p = 0.008, 0.025, and 0.003, respectively) (Fig. 2C). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.